/5
0 avis
Rituximab and mycophenolate mofetil in interstitial lung disease (EVER-ILD): one-year follow up results of a randomized controlled trial
Archive ouverte
Edité par CCSD ; European Respiratory Society -
International audience
Consulter en ligne
Chargement des enrichissements...